ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1194

Enhanced IL-1β and IL-6 Production In Gout Patients Upon Stimulation With Mono Sodium Urate Crystals and Synergizing Agents Compared To Healthy Volunteers

Tania O. Crisan1, Maartje Cleophas1, Mihai G. Netea1, Tim L. Jansen2 and Leo A. Joosten3, 1Department of Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 3Department of Medicine, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: cytokines, gout, IL-1, monocytes and uric acid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Metabolic and Crystal Arthropathies I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Gout is an autoinflammatory disease characterized by the deposition of monosodium urate (MSU) crystals in the joints of hyperuricaemic patients and subsequent attacks of severe gouty arthritis. It is known for centuries that the MSU crystals are the necessary causative agent of gout but, in addition, it is now proven that MSU requires synergizing stimuli to induce high cytokine responses, relevant for the clinical picture of gout. Here we investigate the inflammatory response in gout patients and healthy controls upon stimulation with MSU crystals in combination with other ligands. We also investigate the effects of elevated uric acid concentrations on the pro-inflammatory cytokine production in human immune cells.

Methods:

Peripheral blood mononuclear cells (PBMCs) were harvested from patients diagnosed with crystal-proven gout and from age matched healthy volunteers. Cells were stimulated for 24 hours with Pam3Cys or palmitic acid (C16) in the presence or absence of MSU crystals. In separate experiments, the cells were first treated with uric acid or left untreated for 24h and then subjected to stimulation with Pam3Cys or LPS for another 24h. Production of IL-1beta, IL-6 was assessed using specific sandwich ELISA kits. mRNA levels were measured using quantitative real time PCR. Differences were assessed using the Mann-Whitney test and a p-value<0.05 was considered statistically significant.

Results:

MSU crystals stimulation alone did not induce detectable levels of IL-1β or IL-6 neither in patients nor in controls, however, a significant synergy between MSU and Pam3Cys or C16 was observed. Of high importance, significantly higher levels of IL-1β and IL-6 were observed in patients compared to controls. Subsequently, when cells were pretreated with uric acid, an enhanced cytokine production was observed in cells stimulated with Pam3Cys or LPS in the presence or absence of MSU, however, uric acid alone did not induce this effect. This enhanced cytokine production correlated with higher mRNA levels observed in uric acid pre-treated cells.

Conclusion:

Enhanced cytokine production was observed in cells originating from gout patients compared to controls when stimulated with MSU crystals and synergizing stimuli. Similar trends could be identified when the cells were pre-treated with high uric acid levels in vitro and then subjected to MSU crystals stimulation. These results indicate that high uric acid levels could have an effect on immune cells and facilitate higher responses upon encounter of inflammatory stimuli and this could be a mechanism for the enhanced pro-inflammatory response observed in gout patients.


Disclosure:

T. O. Crisan,
None;

M. Cleophas,
None;

M. G. Netea,
None;

T. L. Jansen,
None;

L. A. Joosten,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/enhanced-il-1%ce%b2-and-il-6-production-in-gout-patients-upon-stimulation-with-mono-sodium-urate-crystals-and-synergizing-agents-compared-to-healthy-volunteers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology